PATENT CLAIM ANALYSIS

Application Number: 15934539
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-09
Patent Classification: ["514", "690000"]

Abstract:
This invention provides an effective method and a composition for treating neurodegenerative diseases and conditions of the central and peripheral nervous system by stimulating neurogenesis by the use isoxylitones or an isomer, acid analog, a salt or a solvate, thereof.

Claim (Index 6):
The method of claim  1 , wherein isoxylitones (E/Z)-(1-(3,5,5-trimethylcyclohex-2-enylidene)propan-2-one or an isomer, an acid analog, a salt, or a solvate thereof, causes differentiation and proliferation by activating transcription genes NeuroD1 and Neurogenin (Ngn).

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 1.29412
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12500073', '12939897', '13269507', '14170344', '13744220']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7741022778836472
- 35 USC 102 Novelty (BERT): 0.5133391713409532
- Combined Prediction Score: 0.7480259672293778
- Mean Citation Score: 269.960514
- Max Citation Score: 270.34753
- Similarity Product: 174.39993404311662

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test